LPL Financial
VIR icon

LPL Financial’s Vir Biotechnology VIR Stock Holding History

LPL Financial’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$403K Sell
39,519
-12,481
-24% -$119K ﹤0.01% 5219
2026
Q1 		$466K Buy
52,000
+13,250
+34% +$106K ﹤0.01% 4817
2025
Q4 		$234K Buy
38,750
+2,600
+7% +$15.5K ﹤0.01% 5349
2025
Q3 		$206K Buy
36,150
+14,924
+70% +$76.3K ﹤0.01% 5330
2025
Q2 		$107K Buy
21,226
+6,817
+47% +$36.5K ﹤0.01% 5254
2025
Q1 		$93.4K Buy
+14,409
New +$128K ﹤0.01% 5056
2024
Q2 		– Sell
-30,734
Closed -$311K – 5149
2024
Q1 		$311K Buy
+30,734
New +$313K ﹤0.01% 4165
2022
Q4 		– Sell
-10,859
Closed -$209K – 4568
2022
Q3 		$209K Buy
+10,859
New +$276K ﹤0.01% 3896
2021
Q2 		– Sell
-5,598
Closed -$287K – 4311
2021
Q1 		$287K Buy
+5,598
New +$302K ﹤0.01% 3500

Other funds holding VIR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GP
GSK plc London $602M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

LPL Financial's VIR Position: Q2 2026 in Review

LPL Financial reduced its Vir Biotechnology (VIR) stake by 24% in Q2 2026, selling an estimated $119K and leaving 39,519 shares worth $403K. The position accounts for ﹤0.01% of the portfolio, ranked #5219.

LPL Financial first reported a position in VIR in Q1 2021 and has held it in 9 quarters since. The position peaked at $466K in Q1 2026. 237 funds tracked by Wall St. Rank hold VIR as of Q2 2026.

  • LPL Financial held 39,519 shares of Vir Biotechnology worth $403K as of Q2 2026.
  • LPL Financial sold 12,481 Vir Biotechnology shares in Q2 2026, an estimated $119K.
  • Vir Biotechnology made up ﹤0.01% of LPL Financial's portfolio in Q2 2026, its #5219 holding.
  • LPL Financial first reported a position in Vir Biotechnology in Q1 2021 and has held it in 9 quarters since.
  • LPL Financial's Vir Biotechnology position peaked at $466K in Q1 2026.
  • 237 funds tracked by Wall St. Rank held Vir Biotechnology as of Q2 2026.

Based on LPL Financial's 13F filing for Q2 2026, filed 7 Aug 2026.